Pipeline — registered trials by phase
Prospective Clinical Evaluation of BD Spinal Needles
— · Analgesia, Anesthesia · Completed · est. 2022-07-22
Investigational Study With the BD PosiFlush™ SafeScrub on NADs
— · CRBSI - Catheter Related Bloodstream Infection · Completed · est. 2026-04-30
BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study
— · Type 1 Diabetes Mellitus · Completed · est. 2016-02
Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System With Cervical Specimens
— · Uterine Cervical Neoplasms · Completed · est. 2016-03
BD MiniDraw™ Capillary System Clinical Equivalence Study
— · Healthy, Disease, Chronic, Acute Disease · Completed · est. 2022-10-24
Efficiency, and Emergency Department Nurse Preference Between 2 Methods of Visualization: A Pilot Study
— · Catheter Related Complication · Completed · est. 2019-10-14
Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle
— · Diabetes · Completed · est. 2018-04-24
BD SiteRite(TM) 9 Ultrasound System - Clinical Study
— · BD SiteRite 9 for VAD Insertion · Completed · est. 2026-01-09
Evaluation of the BD OneFlow Acute Leukemia Panel on the BD FACSLyric Flow Cytometer
— · Acute Leukemia · Completed · est. 2024-06-29
Clinical Evaluation of BD NEXT Pen Needle
— · Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1 · Completed · est. 2012-12
Prospective Clinical Evaluation of BD NRFit™ Devices and Accessories.
— · Anesthesia, Analgesia · Completed · est. 2024-05-28
BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study
— · BD Prevue II for Peripheral Intravenous Catheter Placement · Completed · est. 2025-09-23
Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens
— · Cervical Neoplasms, Human Papillomavirus · Completed · est. 2018-12-12
The Continuity Study
— · Blood Pressure · Recruiting · est. 2027-01
Evaluation of Blood Volume and Perceived Pain During Fingerstick Monitoring of Blood Glucose
— · Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 · Completed · est. 2008-09
Prospective Healthy Volunteer Study of the Securis™ Stabilization Device
— · Peripheral Intavenous Catheter Stabilization · Completed · est. 2021-07-20
Personal BP - CAI Study
— · Blood Pressure · Recruiting · est. 2027-01
Prospective Observational Study of the Power PICC Family of Devices and Accessories
— · Peripherally Inserted Central Catheter · Completed · est. 2022-01-05
BD Veritor™ At-Home and BD Veritor™ Professional
— · Upper Respiratory Infection · Completed · est. 2023-03-09
Clinical Validation of BACTEC™ Plus Aerobic/F Culture Vials Compared With Equivalent Product
— · Sepsis · Completed · est. 2025-10-23
Investigational On-body Injector Clinical Study
— · Healthy Volunteers · Completed · est. 2023-02-08
European Clinical Evaluation of the BD HPV Assay on the BD Viper LT System
— · Uterine Cervical Neoplasms · Completed · est. 2013-11
A 7 Day Adhesive Device Wear Study to Evaluate BD StatLock™ Devices
— · Peripheral Intravenous Catheter Stabilization · Completed · est. 2021-08-23
Study of Effectiveness of Smaller Gauge Fenestrated Catheters for Use in IV Contrast Enhanced CT Scans
— · Contrast Enhanced Computed Tomography · Completed · est. 2013-02
Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen Needles
— · Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 · Completed · est. 2012-05
A Comparison Study of Prototype Continuous Glucose Sensors in the Intradermal and Subcutaneous Spaces
— · Diabetes · Completed · est. 2009-04
Multi-day (3) In-patient Evaluation of Intradermal Versus Subcutaneous Basal and Bolus Insulin Infusion
— · Diabetes · Completed · est. 2012-05
Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating
— · Diabetes Mellitus, Type 1 · Completed · est. 2007-12
Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth
— · Preoperative Skin Preparation · Completed · est. 2017-08-04
Effectiveness of an Antimicrobial Agent for Preoperative Skin Preparation
— · Preoperative Skin Preparation · Completed · est. 2017-08-24
Study on the Effects on Blood Glucose Following Intradermal and Subcutaneous Dosing of Insulin in Diabetic Patients
— · Diabetes · Completed · est. 2010-10
Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered Either Intradermally or Subcutaneously
— · Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 · Completed · est. 2010-03
No registered trials in this stage.
Chlorhexidine GluconateChlorhexidine Gluconate
Source: ClinicalTrials.gov (trials where Becton Dickinson is lead sponsor; 53 active or completed) and Drugs@FDA (1 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- SCHEDULE 13G2026-08-07SCHEDULE 13G
- 10-Q2026-08-06Quarterly report
- SCHEDULE 13G2026-08-06SCHEDULE 13G
- 8-K2026-08-06Current report (material event)
- 8-K2026-07-22Current report (material event)
- 11-K2026-06-2911-K
- 11-K2026-06-2911-K
- 25-NSE2026-06-0425-NSE
- 8-K2026-05-29Current report (material event)
- SD2026-05-22SD
- CERT2026-05-21CERT
- 8-A12B2026-05-208-A12B
- 8-K2026-05-20Current report (material event)
- SCHEDULE 13G/A2026-05-15SCHEDULE 13G/A
- 424B22026-05-13424B2
- 8-K2026-05-12Current report (material event)
- FWP2026-05-11FWP
- 424B22026-05-11424B2
- S-82026-05-07Employee stock plan
- S-82026-05-07Employee stock plan
- 10-Q2026-05-07Quarterly report
- 8-K/A2026-05-07Current report (amended)
- 8-K2026-05-07Current report (material event)
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- 8-K2026-04-29Current report (material event)
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- 8-K2026-04-09Current report (material event)
- 8-K2026-04-02Current report (material event)
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- 8-K2026-02-25Current report (material event)
- 8-K2026-02-10Current report (material event)
- 10-Q2026-02-09Quarterly report
- 8-K2026-02-09Current report (material event)
- 8-K2026-02-09Current report (material event)
- 8-K2026-02-05Current report (material event)
- 8-K2026-02-05Current report (material event)
- 8-K2026-01-30Current report (material event)
- SCHEDULE 13G/A2026-01-30SCHEDULE 13G/A
- 8-K2026-01-06Current report (material event)
- ARS2025-12-18Annual report to holders
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.